Candriam S.C.A. Macrogenics Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$3.01 - $5.22 $961,842 - $1.67 Million	-319,549 Reduced 61.74%	198,043 $685,000
Q1 2022 May 13, 2022	SELL	$8.12 - $16.9 $244,712 - $509,315	-30,137 Reduced 5.5%	517,592 $4.56 Million
Q4 2021 Feb 10, 2022	SELL	$15.91 - $21.88 $967,232 - $1.33 Million	-60,794 Reduced 9.99%	547,729 $8.79 Million
Q2 2021 Jul 20, 2021	SELL	$20.49 - $35.63 $1.39 Million - $2.41 Million	-67,607 Reduced 10.0%	608,523 $16.3 Million
Q1 2021 Apr 29, 2021	BUY	$18.99 - $33.2 $94 - $166	5 Added 0.0%	676,130 $14.8 Million
Q4 2020 Jan 22, 2021	BUY	$19.41 - $26.0 $1.83 Million - $2.45 Million	94,271 Added 16.2%	676,125 $15.5 Million
Q3 2020 Oct 19, 2020	BUY	$24.69 - $31.6 $2.8 Million - $3.58 Million	113,421 Added 24.21%	581,854 $14.7 Million
Q2 2020 Jul 23, 2020	SELL	$5.2 - $29.12 $1.45 Million - $8.13 Million	-279,330 Reduced 37.36%	468,433 $13.1 Million
Q4 2019 Jan 21, 2020	SELL	$7.95 - $12.27 $57,438 - $88,650	-7,225 Reduced 0.96%	747,763 $8,000
Q3 2019 Oct 21, 2019	BUY	$12.44 - $17.48 $49,760 - $69,920	4,000 Added 0.53%	754,988 $10,000
Q2 2019 Aug 01, 2019	BUY	$14.51 - $19.71 $1.24 Million - $1.69 Million	85,500 Added 12.85%	750,988 $12.7 Million
Q1 2019 May 02, 2019	BUY	$11.11 - $25.6 $1.36 Million - $3.14 Million	122,501 Added 22.56%	665,488 $12 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $2.19 Million - $3.99 Million	186,387 Added 52.27%	542,987 $6.9 Million
Q3 2018 Nov 07, 2018	BUY	$19.26 - $23.46 $5.1 Million - $6.22 Million	265,000 Added 289.3%	356,600 $7.65 Million
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $328,348 - $409,522	16,600 Added 22.13%	91,600 $1.89 Million
Q4 2017 Feb 07, 2018	BUY	$16.19 - $20.3 $1.21 Million - $1.52 Million	75,000	75,000 $1.43 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account